American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

LABT historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of LABT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
LABT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
LABT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
LABT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in LABT holdings by institutional investors

Insider Trading

Quarterly net insider trading by LABT's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Revolving Door

Former government officials who have lobbied for LABT

Quiver Logo

No former government officials on record as having lobbied for LABT

Revolving Door Dashboard
Corporate Lobbying

LABT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

LABT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
LABT Income Statement
LABT Balance Sheet
LABT Cash Flow
U.S. Patents

New LABT patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to LABT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
LABT News

Recent insights relating to LABT

CNBC Recommendations

Recent picks made for LABT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LABT

LABT Analyst Ratings

LABT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
LABT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $LABT stock a Buy, Sell, or Hold?

  • What is the price target for $LABT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

LABT Top Shareholders
Shareholder
Shares Held
LABT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $LABT stock?

  • Who owns the most shares of $LABT stock?

  • What funds own $LABT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

LABT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view LABT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About LABT

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

  • Address University Park, FL
  • Market Cap 4.7 million
  • Employees 0
  • Industrial Classification N/A

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Historical Stock Prices

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) closed at $1.99 on September 22, 2026. Over the past year its adjusted close ranged from $1.85 to $86.50. Daily prices go back to April 23, 2026, 105 trading days in all.

  • 1 month-11.16%
  • 3 months-49.87%
  • Year to date—
  • 1 year—
  • 3 years—
  • 5 years—
  • Max-97.70%
See every congressional and insider trade on the LABT price chart

Quiver Premium charts LABT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 2.08 2.10 1.90 1.99 1.99 130,940
Sep 21, 2026 1.99 2.08 1.92 2.05 2.05 362,761
Sep 18, 2026 1.92 2.15 1.89 1.99 1.99 290,222
Sep 17, 2026 2.04 2.05 1.84 1.86 1.86 125,314
Sep 16, 2026 2.18 2.18 2.08 2.09 2.09 55,405
Sep 15, 2026 2.17 2.17 2.07 2.17 2.17 98,031
Sep 14, 2026 2.25 2.28 2.06 2.12 2.12 57,921
Sep 11, 2026 2.11 2.23 2.03 2.22 2.22 143,975
Sep 10, 2026 2.24 2.30 2.03 2.05 2.05 286,736
Sep 9, 2026 2.20 2.61 2.13 2.32 2.32 5,084,489
Sep 8, 2026 1.89 2.27 1.89 2.18 2.18 499,983
Sep 4, 2026 1.88 1.98 1.87 1.88 1.88 91,570
Sep 3, 2026 2.10 2.16 1.86 1.90 1.90 251,964
Sep 2, 2026 2.47 2.64 2.06 2.07 2.07 516,373
Sep 1, 2026 2.68 2.86 2.53 2.76 2.76 3,568,505
Aug 31, 2026 2.23 2.58 2.22 2.50 2.50 13,655,455
Aug 28, 2026 2.44 2.44 2.22 2.30 2.30 96,155
Aug 27, 2026 2.62 2.62 2.35 2.49 2.49 219,920
Aug 26, 2026 2.23 2.57 2.20 2.45 2.45 386,271
Aug 25, 2026 2.10 2.35 2.10 2.29 2.29 213,343
Aug 24, 2026 2.20 2.29 2.10 2.13 2.13 39,957
Aug 21, 2026 2.18 2.34 2.17 2.24 2.24 70,560
Aug 20, 2026 2.17 2.24 2.13 2.19 2.19 85,410
Aug 19, 2026 2.23 2.35 2.16 2.24 2.24 80,322
Aug 18, 2026 2.14 2.30 2.04 2.30 2.30 102,271
Aug 17, 2026 2.15 2.25 2.13 2.16 2.16 32,677
Aug 14, 2026 2.33 2.33 2.07 2.27 2.27 106,284
Aug 13, 2026 2.33 2.35 2.17 2.33 2.33 287,078
Aug 12, 2026 2.29 2.46 2.22 2.36 2.36 70,721
Aug 11, 2026 2.26 2.38 2.24 2.36 2.36 46,615
Aug 10, 2026 2.19 2.45 2.18 2.35 2.35 194,398
Aug 7, 2026 2.19 2.27 2.14 2.22 2.22 46,175
Aug 6, 2026 2.26 2.35 2.13 2.23 2.23 102,606
Aug 5, 2026 2.21 2.50 2.21 2.31 2.31 163,882
Aug 4, 2026 2.12 2.32 2.02 2.22 2.22 165,391
Aug 3, 2026 2.00 2.24 1.95 2.16 2.16 240,475
Jul 31, 2026 1.90 2.16 1.90 2.02 2.02 255,350
Jul 30, 2026 1.99 1.99 1.85 1.93 1.93 115,868
Jul 29, 2026 2.01 2.05 1.80 1.98 1.98 144,891
Jul 28, 2026 2.26 2.50 1.93 2.10 2.10 296,116
Jul 27, 2026 2.43 2.83 2.26 2.50 2.50 299,059
Jul 24, 2026 2.96 2.98 2.56 2.64 2.64 303,131
Jul 23, 2026 3.55 3.55 2.77 3.06 3.06 2,060,651
Jul 22, 2026 6.49 6.85 3.00 3.41 3.41 79,569,743
Jul 21, 2026 1.87 1.92 1.73 1.86 1.86 47,581
Jul 20, 2026 1.87 1.97 1.84 1.93 1.93 35,083
Jul 17, 2026 1.74 1.95 1.66 1.89 1.89 90,591
Jul 16, 2026 2.28 2.28 1.76 1.85 1.85 194,853
Jul 15, 2026 2.36 2.85 2.15 2.43 2.43 983,114
Jul 14, 2026 2.65 2.70 2.50 2.55 2.55 81,852
Jul 13, 2026 2.54 2.92 2.41 2.73 2.73 241,243
Jul 10, 2026 2.52 2.75 2.37 2.61 2.61 214,083
Jul 9, 2026 2.30 2.80 2.29 2.64 2.64 286,147
Jul 8, 2026 2.40 2.40 2.10 2.38 2.38 107,291
Jul 7, 2026 2.73 2.82 2.31 2.39 2.39 228,022
Jul 6, 2026 2.82 3.10 2.41 2.74 2.74 684,607
Jul 2, 2026 3.15 3.25 2.61 2.75 2.75 774,625
Jul 1, 2026 3.23 3.50 3.09 3.30 3.30 308,541
Jun 30, 2026 3.43 3.59 2.96 3.14 3.14 303,785
Jun 29, 2026 3.53 3.59 3.27 3.48 3.48 290,435
Jun 26, 2026 3.50 3.80 3.35 3.51 3.51 406,543
Jun 25, 2026 3.75 4.04 3.26 3.43 3.43 668,808
Jun 24, 2026 3.90 4.29 3.46 3.72 3.72 530,887
Jun 23, 2026 3.53 4.72 3.42 3.97 3.97 383,790
Jun 22, 20261-for-10 reverse split 3.82 4.22 3.49 3.65 3.65 154,000
Jun 18, 2026 0.5630 0.5895 0.3660 0.3861 3.86 1,830,790
Jun 17, 2026 0.7340 0.7472 0.5840 0.6022 6.02 1,065,941
Jun 16, 2026 0.7201 0.7499 0.7200 0.7340 7.34 74,016
Jun 15, 2026 0.7654 0.7700 0.7117 0.7390 7.39 204,011
Jun 12, 2026 0.7200 0.7741 0.6700 0.7674 7.67 301,530
Jun 11, 2026 0.7500 0.7700 0.7154 0.7228 7.23 175,907
Jun 10, 2026 0.6801 0.7810 0.6706 0.7587 7.59 529,110
Jun 9, 2026 0.6453 0.7290 0.6110 0.6802 6.80 260,842
Jun 8, 2026 0.6669 0.6680 0.6201 0.6403 6.40 321,510
Jun 5, 2026 0.6990 0.7095 0.6201 0.6680 6.68 355,476
Jun 4, 2026 0.6480 0.7748 0.6401 0.6750 6.75 703,648
Jun 3, 2026 0.6200 0.6498 0.6100 0.6470 6.47 237,364
Jun 2, 2026 0.6302 0.6302 0.5900 0.6200 6.20 446,615
Jun 1, 2026 0.6667 0.6700 0.6100 0.6499 6.50 502,763
May 29, 2026 0.7200 0.7200 0.6641 0.6750 6.75 424,795
May 28, 2026 0.7100 0.7299 0.6901 0.7299 7.30 300,241
May 27, 2026 0.6984 0.7399 0.6702 0.7333 7.33 845,822
May 26, 2026 0.6650 0.7399 0.6600 0.7120 7.12 435,488
May 22, 2026 0.7694 0.7694 0.7000 0.7066 7.07 552,808
May 21, 2026 0.7510 0.8181 0.7340 0.7698 7.70 914,494
May 20, 2026 0.8058 0.8080 0.7000 0.7530 7.53 926,564
May 19, 2026 0.8588 0.8951 0.6900 0.8666 8.67 1,512,132
May 18, 2026 1.35 1.47 0.9200 0.9502 9.50 37,880,454
May 15, 2026 1.98 1.98 1.41 1.50 15.00 235,139
May 14, 2026 2.83 2.83 1.92 1.96 19.60 411,343
May 13, 2026 3.15 3.21 2.95 2.95 29.50 109,792
May 12, 2026 3.12 3.32 3.12 3.22 32.20 224,633
May 11, 2026 3.14 3.18 3.11 3.16 31.60 149,057
May 8, 2026 3.25 3.25 2.93 3.10 31.00 152,214
May 7, 2026 3.17 3.40 3.17 3.30 33.00 367,723
May 6, 2026 2.93 3.28 2.93 3.13 31.30 287,841
May 5, 2026 2.91 3.25 2.91 3.10 31.00 398,675
May 4, 2026 2.77 3.30 2.77 3.26 32.60 820,593
May 1, 2026 4.22 4.61 3.13 3.43 34.30 46,400,916
Apr 30, 2026 3.51 3.55 2.58 2.66 26.60 306,985
Apr 29, 2026 3.45 3.86 3.31 3.59 35.90 170,022
Apr 28, 2026 3.63 4.04 3.14 3.89 38.90 276,799
Apr 27, 2026 5.75 6.06 3.60 3.66 36.60 580,797
Apr 24, 2026 8.65 9.40 7.01 7.35 73.50 5,211,081
Apr 23, 2026 8.00 9.82 5.75 8.65 86.50 137,559

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Lakewood-Amedex Biotherapeutics Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at LABT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation